Literature DB >> 28522043

Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients.

Patrizia Weber1, S Morteza Seyed Jafari2, Nikhil Yawalkar1, Robert E Hunger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28522043     DOI： 10.1016/j.jaad.2017.02.026

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  12 in total

1.  Off-label studies on apremilast in dermatology: a review.

Authors:  Nolan J Maloney; Jeffrey Zhao; Kyle Tegtmeyer; Ernest Y Lee; Kyle Cheng
Journal:  J Dermatolog Treat       Date:  2019-04-02       Impact factor: 3.359

Review 2.  [Drug therapy of acne inversa].

Authors:  S Schneider-Burrus; E Arpa; C Kors; T Stavermann; R Sabat; G Kokolakis
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

Review 3.  Hidradenitis suppurativa.

Authors:  Robert Sabat; Gregor B E Jemec; Łukasz Matusiak; Alexa B Kimball; Errol Prens; Kerstin Wolk
Journal:  Nat Rev Dis Primers       Date:  2020-03-12       Impact factor: 52.329

Review 4.  Review of Current Immunologic Therapies for Hidradenitis Suppurativa.

Authors:  Victoria K Shanmugam; Nadia Meher Zaman; Sean McNish; Faye N Hant
Journal:  Int J Rheumatol       Date:  2017-08-20

Review 5.  Systematic review of immunomodulatory therapies for hidradenitis suppurativa.

Authors:  Shi Yu Derek Lim; Hazel H Oon
Journal:  Biologics       Date:  2019-05-13

6.  Treatment of generalized granuloma annulare with apremilast: A report of 2 cases.

Authors:  Stacy Blum; David Altman
Journal:  JAAD Case Rep       Date:  2019-10-24

Review 7.  Apremilast for the treatment of hidradenitis suppurativa associated with psoriatic arthritis in multimorbid patients: Case report and review of literature.

Authors:  Simone Garcovich; Giulia Giovanardi; Dalma Malvaso; Clara De Simone; Ketty Peris
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

Review 8.  Hidradenitis Suppurativa: Host-Microbe and Immune Pathogenesis Underlie Important Future Directions.

Authors:  Simon W Jiang; Melodi Javid Whitley; Paula Mariottoni; Tarannum Jaleel; Amanda S MacLeod
Journal:  JID Innov       Date:  2021-01-12

Review 9.  New and Emerging Targeted Therapies for Hidradenitis Suppurativa.

Authors:  Adela Markota Čagalj; Branka Marinović; Zrinka Bukvić Mokos
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

Review 10.  Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm.

Authors:  S Morteza Seyed Jafari; Robert E Hunger; Christoph Schlapbach
Journal:  Front Med (Lausanne)       Date:  2020-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.